INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 439m ago
HOUSE PTR38m ago
SEC 13F38m ago
ROBINHOOD CHAIN38m ago
Public company

Cullinan Therapeutics, Inc.

CGEMCIK 0001789972

EDGAR filingsOpen in network
Price$11.31
1 year+54.7%
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score5
Connections with evidence2

CGEM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
MJ
Michaelson JenniferChief Scientific Officer
CGEMCullinan Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$16K
3,805 sh
Nov 5, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 6, 2026
  • ← Insider ofevidence
    Michaelson JenniferChief Scientific Officer · Nov 6, 2026
Nov 6, 2026
traded Nov 5, 2026
+1d
SEC FORM 4

Evidence

5
MJ
Michaelson JenniferChief Scientific Officer
CGEMCullinan Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
4,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

3
MJ
Michaelson JenniferChief Scientific Officer
CGEMCullinan Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
3,805 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence